Phio Pharmaceuticals Corp.

Ownership Transactions Reported by 12 Insiders

Symbol
PHIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
11 Apex Drive, Suite 300 A, Pmb 2006, Marlborough, MA

Insiders trading volume in the past year

Phio Pharmaceuticals Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gerrit Dispersyn President & CEO, Director $321K Mar 1, 2022
Lisa C. Carson VP, Finance and Administration $89.3K Sep 11, 2025
Robert L. Ferrara Director $73.5K +$10.6K +16.9% Sep 11, 2025
Robert J. Bitterman Chairman, Pres. & CEO, Director $65.7K +$16.4K +33.3% Sep 11, 2025
Patricia A. Bradford Director $51.6K Sep 11, 2025
Curtis Lockshin Director $35.3K Sep 11, 2025
H. Paul Dorman Director $30.8K Feb 15, 2022
Jonathan E. Freeman Director $30.5K Sep 11, 2025
David H. Deming Director $26.6K Sep 11, 2025
Caitlin Kontulis Secretary & VP Finance & Admin $10.2K Mar 1, 2024
Robert M. Infarinato Vp, Cfo $8.14K Sep 11, 2024
Geert Cauwenbergh Director $6.4K Feb 17, 2023

Recent Insider Transactions by Companies or Individuals for Phio Pharmaceuticals Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.